![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Nextremity Earns FDA Clearance for TMT Joint System
Nextremity Earns FDA Clearance for TMT Joint System
![ClearanceStamp_Orange.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Orange.gif?t=1609798625&width=430)
The FDA granted Nextremity Solutions 510(k) clearance for its tarsometatarsal joint device, an addition to the InCore Lapidus system used for first tarsometatarsal fusion.
The device is indicated as a three-part construct for internal fixation for second and third tarsometatarsal infusion, also known as Lisfranc joint fusion.
The joint system, which is made up of a post and two screws, is used to improve a patient’s midfoot stability and restore the foot’s anatomical arch. The system comes with a set of accessory instruments for implant preparation and insertion.
Upcoming Events
-
21Oct